Pherin Pharmaceuticals

PHERINE-BASED THERAPIES

Based upon its proprietary technology, Pherin Pharmaceuticals is strongly positioned to develop a portfolio of pherine-based therapies that are for convenient use by patients in the home setting and superior to existing medications for the treatment of various neuropsychiatric and neuroendocrine disorders.

LATEST NEWS
On February 1st, 2008 Pherin Pharmaceuticals announced that it has commenced Phase 2B clinical trials in the use of its proprietary drug PH94B, for the treatment of Social Phobia.

PRODUCTS
Pherin Pharmaceuticals is developing products for the acute relief of symptoms in these conditions:

Social Phobia: PH94B
Hot Flashes: PH80HF
PMDD & PMS: PH80PMS